Jianfeng International Trade Obtain Network Freight Platform Qualification as the First in Jinhua and Quzhou
Release time:
2020-08-05
After the interconnection monitoring by the transportation department of Zhejiang Province, the network freight platform of Jianfeng International Trading Company passed the online service capability audit, interface access audit, eight capability identification and other audit procedures, and successfully obtained the road transportation business license with the qualification of "network freight" on July 2. It is understood that Jianfeng International Trade is currently the first enterprise in Jinhua and Quzhou to obtain this qualification.
Since obtaining the qualification of "car-free carrier" pilot enterprise, Jianfeng International Trade has started to build a network freight platform. Especially since this year, Jianfeng International Trade has obtained the value-added telecom service license in March. In April, he obtained the "Level 3 Equal Insurance" license. In early May, according to the relevant requirements of Zhejiang Province, according to the "Zhejiang Province Network Freight Information Monitoring System Access Guide" to carry out enterprise network freight platform system transformation, and officially connected to Zhejiang Province platform for trial operation that month, on June 25, the waybill reached the standard, with an abnormal rate of 0%.
has obtained the qualification of online freight transportation platform, which provides more development space for Jianfeng International Trade to promote the transformation of enterprise management, further expand the market, scale up and expand the market coverage of transportation business and storage business. At the same time, it also forces enterprises to speed up the transformation of intelligent management and the transformation of storage business and transportation business to intelligent logistics. Relying on the network freight platform, Jianfeng International Trade will fully integrate the existing storage and logistics resources, strive to achieve marketing projects, capacity coordination, service customization, de-intermediation and digitization, and realize the closed-loop operation of PDCA supply chain system, thus guiding the return of integrated vehicles and transportation services, and continuously promoting the regional logistics market from low, small and scattered space to resource sharing, value sharing and win-win cooperation. At the same time, the advantages of 110000 square meters of warehouse and 15000 square meters of railway station yard of Jianfeng International Trade can also be brought into better play, changing from traditional warehousing and logistics to innovative logistics and transportation modes such as network freight platform, multimodal transportation and digital warehousing.
At present, the peak international trade transportation business is being fully moved to online operation and management, realizing online business, online capacity, online transaction, full track monitoring, and realizing full chain data. The network freight platform has now completed the development of functions such as vehicle track management and monitoring, online verification of vehicle shippers, two-way evaluation of vehicle shippers, capacity pool, online instant payment methods, etc., and its competitiveness is gradually being reflected. (zhang zhuoran, huang zhiyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page